JPS52139074A - Morpholine derivative and mental version drug composition containing same - Google Patents

Morpholine derivative and mental version drug composition containing same

Info

Publication number
JPS52139074A
JPS52139074A JP2495676A JP2495676A JPS52139074A JP S52139074 A JPS52139074 A JP S52139074A JP 2495676 A JP2495676 A JP 2495676A JP 2495676 A JP2495676 A JP 2495676A JP S52139074 A JPS52139074 A JP S52139074A
Authority
JP
Japan
Prior art keywords
mental
composition containing
drug composition
containing same
morpholine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2495676A
Other languages
English (en)
Inventor
Jiyosefu Makuruurin Baanaado
Jiyon Girudofuoodo Aren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB2001374A priority Critical patent/GB1452701A/en
Priority to ZA00752388A priority patent/ZA752388B/xx
Priority to US05/567,011 priority patent/US4010266A/en
Priority to AU80215/75A priority patent/AU488125B2/en
Priority to IN793/CAL/1975A priority patent/IN141021B/en
Priority to DE19752519101 priority patent/DE2519101A1/de
Priority to NL7505140A priority patent/NL7505140A/xx
Priority to LU72408A priority patent/LU72408A1/xx
Priority to AT341575A priority patent/AT344188B/de
Priority to DD185870A priority patent/DD121641A5/xx
Priority to FR7514148A priority patent/FR2269953B1/fr
Priority to CA226,313A priority patent/CA1067075A/en
Priority to SE7505237A priority patent/SE425312B/xx
Priority to DK198675A priority patent/DK198675A/da
Priority to FI751344A priority patent/FI751344A7/fi
Priority to JP50055307A priority patent/JPS50154273A/ja
Priority to CH592175A priority patent/CH610894A5/xx
Priority to BE156138A priority patent/BE828822A/xx
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to JP2495676A priority patent/JPS52139074A/ja
Priority to AR258562A priority patent/AR209436A1/es
Priority to US05/735,125 priority patent/US4088814A/en
Priority to US05/735,124 priority patent/US4049808A/en
Priority to AT266977A priority patent/AT344715B/de
Priority to AT266877A priority patent/AT344714B/de
Publication of JPS52139074A publication Critical patent/JPS52139074A/ja
Priority to CH22779A priority patent/CH634569A5/de
Priority to KE3021A priority patent/KE3021A/xx
Priority to HK55/80A priority patent/HK5580A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2495676A 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same Pending JPS52139074A (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
ZA00752388A ZA752388B (en) 1974-05-07 1975-03-15 Morpholine derivatives
US05/567,011 US4010266A (en) 1974-05-07 1975-04-10 Phenylvinyl morpholine compounds
AU80215/75A AU488125B2 (en) 1974-05-07 1975-04-16 Morpholine derivatives
IN793/CAL/1975A IN141021B (ja) 1974-05-07 1975-04-19
DE19752519101 DE2519101A1 (de) 1974-05-07 1975-04-29 Morpholinderivate
NL7505140A NL7505140A (nl) 1974-05-07 1975-05-01 Werkwijze ter bereiding van morfolinederivaten, werkwijze ter vervaardiging van farmaceutische preparaten hiermede, alsmede de aldus gevormde voortbrengselen.
AT341575A AT344188B (de) 1974-05-07 1975-05-05 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen
LU72408A LU72408A1 (ja) 1974-05-07 1975-05-05
FR7514148A FR2269953B1 (ja) 1974-05-07 1975-05-06
CA226,313A CA1067075A (en) 1974-05-07 1975-05-06 Morpholine derivatives
SE7505237A SE425312B (sv) 1974-05-07 1975-05-06 Sett att framstella morfolinderivat
DK198675A DK198675A (da) 1974-05-07 1975-05-06 Morfolinderivater
DD185870A DD121641A5 (ja) 1974-05-07 1975-05-06
FI751344A FI751344A7 (ja) 1974-05-07 1975-05-07
JP50055307A JPS50154273A (ja) 1974-05-07 1975-05-07
CH592175A CH610894A5 (ja) 1974-05-07 1975-05-07
BE156138A BE828822A (fr) 1974-05-07 1975-05-07 Derives de la morpholine
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same
AR258562A AR209436A1 (es) 1974-05-07 1976-04-29 Procedimiento para la fabricacion de derivados de 2-(beta-(fenilo opcionalmente sustituido) vinil)morfolina y 2-(-beta-(fenilo opcionalmente sustituido) etil) morfolina
US05/735,125 US4088814A (en) 1974-05-07 1976-10-22 Morpholine derivatives
US05/735,124 US4049808A (en) 1974-05-07 1976-10-22 2-Phenyl ethyl morpholine compounds
AT266977A AT344715B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung eines neuen morpholinderivates und von dessen saeureadditionssalzen
AT266877A AT344714B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen
CH22779A CH634569A5 (de) 1974-05-07 1979-01-10 Verfahren zur herstellung von morpholinderivaten.
KE3021A KE3021A (en) 1974-05-07 1980-02-06 Morpholine derivatives
HK55/80A HK5580A (en) 1974-05-07 1980-02-21 Morpholine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (1)

Publication Number Publication Date
JPS52139074A true JPS52139074A (en) 1977-11-19

Family

ID=26254367

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50055307A Pending JPS50154273A (ja) 1974-05-07 1975-05-07
JP2495676A Pending JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP50055307A Pending JPS50154273A (ja) 1974-05-07 1975-05-07

Country Status (20)

Country Link
US (1) US4010266A (ja)
JP (2) JPS50154273A (ja)
AR (1) AR209436A1 (ja)
AT (1) AT344188B (ja)
BE (1) BE828822A (ja)
CA (1) CA1067075A (ja)
CH (2) CH610894A5 (ja)
DD (1) DD121641A5 (ja)
DE (1) DE2519101A1 (ja)
DK (1) DK198675A (ja)
FI (1) FI751344A7 (ja)
FR (1) FR2269953B1 (ja)
GB (1) GB1452701A (ja)
HK (1) HK5580A (ja)
IN (1) IN141021B (ja)
KE (1) KE3021A (ja)
LU (1) LU72408A1 (ja)
NL (1) NL7505140A (ja)
SE (1) SE425312B (ja)
ZA (1) ZA752388B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (ja) * 1975-11-13 1977-05-18
DE2731668A1 (de) * 1976-07-14 1978-01-19 Ici Ltd Appetitzuegler
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
AU4455397A (en) 1996-08-23 1998-03-06 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
FI751344A7 (ja) 1975-11-08
SE7505237L (sv) 1975-11-10
AR209436A1 (es) 1977-04-29
HK5580A (en) 1980-02-29
IN141021B (ja) 1977-01-08
AT344188B (de) 1978-07-10
DD121641A5 (ja) 1976-08-12
FR2269953B1 (ja) 1978-10-06
DK198675A (da) 1975-11-08
ZA752388B (en) 1976-03-31
BE828822A (fr) 1975-11-07
ATA341575A (de) 1977-11-15
NL7505140A (nl) 1975-11-11
CH634569A5 (de) 1983-02-15
KE3021A (en) 1980-03-14
CA1067075A (en) 1979-11-27
LU72408A1 (ja) 1976-11-11
AU8021575A (en) 1976-10-21
JPS50154273A (ja) 1975-12-12
GB1452701A (en) 1976-10-13
US4010266A (en) 1977-03-01
CH610894A5 (ja) 1979-05-15
DE2519101A1 (de) 1975-11-20
SE425312B (sv) 1982-09-20
FR2269953A1 (ja) 1975-12-05

Similar Documents

Publication Publication Date Title
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
IL47625A (en) 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ185981A (en) Piperazine derivatives and pharmaceutical compositions
IL48637A0 (en) 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted omega-pentanorprostaglandins and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
PH13466A (en) Oxazole derivatives and pharmaceutical composition containing same
JPS52139074A (en) Morpholine derivative and mental version drug composition containing same
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
ZA756481B (en) 4-methylthio-2-trifluoromethyl methane-sulfonanilide and derivatives thereof
IL46965A (en) Pharmaceutical composition containing heparinoidic factor
JPS52105186A (en) Piperazine derivative and its preparation and medicine containing same
JPS51142094A (en) Iodineecontained product and pharmaceutical composition containing thereof
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
ZA766663B (en) Novel heterocyclic compounds and pharmaceutical composition containing them
JPS5626890A (en) Halovincamone derivatives* thei manufacture and medicinal composition containing it
NZ186158A (en) Disubstituted piperazine derivatives and pharmaceutical compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
HK61881A (en) Diphenylmethane derivatives and pharmaceutical compositions containing them
PH11219A (en) N-substituted-dihydroxyphenethylamine derivatives and pharmaceutical composition thereof
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
PH11045A (en) Thieno-pyridine derivatives and therapeutic composition thereof